Testing the programming of temperament and psychopathology in two independent samples of children with prenatal substance exposure.

Journal Article (Journal Article)

Prenatal programming models have rarely been applied to research on children with prenatal substance exposure, despite evidence suggesting that prenatal drug exposure is a form of stress that impacts neurodevelopmental outcomes and risk for psychopathology. Utilizing data from two longitudinal multisite studies comprising children prenatally exposed to substances as well as a nonexposed comparison group (Maternal Lifestyle Study, n = 1,388; Infant Development, Environment, and Lifestyle study, n = 412), we tested whether early phenotypic indicators of hypothesized programming effects, indexed by growth parameters at birth and infant temperament, served as a link between prenatal substance exposure and internalizing and externalizing behavior at age 5. Latent profile analysis indicated that individual differences in reactivity and regulation for infants prenatally exposed to substances was best characterized by four temperament profiles. These profiles were virtually identical across two independent samples, and demonstrated unique associations with adjustment difficulties nearly 5 years later. Results of path analysis using structural equation modeling also showed that increased prenatal substance exposure was linked to poorer growth parameters at birth, profiles of temperamental reactivity in infancy, and internalizing and externalizing behavior at age 5. This pathway was partially replicated across samples. This study was among the first to link known individual-level correlates of prenatal substance exposure into a specific pathway to childhood problem behavior. Implications for the developmental origins of a child's susceptibility to psychopathology as a result of intrauterine substance exposure are discussed.

Full Text

Duke Authors

Cited Authors

  • Lin, B; Ostlund, BD; Conradt, E; Lagasse, LL; Lester, BM

Published Date

  • August 2018

Published In

Volume / Issue

  • 30 / 3

Start / End Page

  • 1023 - 1040

PubMed ID

  • 30068412

Pubmed Central ID

  • PMC6074047

Electronic International Standard Serial Number (EISSN)

  • 1469-2198

Digital Object Identifier (DOI)

  • 10.1017/S0954579418000391


  • eng

Conference Location

  • United States